Monte Rosa Therapeutics Inc (GLUE)
$8.51 -$0.80 (-8.48%) 4:38 PM 12/11/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$578.12M -
Day's Range
$8.66 - $9.84 -
Volume
1,663,657 -
52 Week Low / High
$3.21 - $12.40 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
GLUE's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 6
- Strong Buy
- 2
- Buy
- 0
- Hold
- 0
- Sell
- 0
- Strong Sell
- $18.50
- Target Price
Company News
-
Monte Rosa Therapeutics Inc (GLUE) Reports Full Year and Q4 2023 Financial Results — Mar 16th, 2024
Research and Development Expenses: Increased to $111.3 million for the full year 2023, up from $85.1 million in 2022. General and Administrative Expenses: Rose to $32.0 million for the full year 2023, compared to $27.3 million in 2022. Net Loss: Grew to $135.4 million for the full year 202...
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$